Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.
Larsson K, Janson C, Ställberg B, Lisspers K, Olsson P, Kostikas K, Gruenberger JB, Gutzwiller FS, Uhde M, Jorgensen L, Johansson G.
Int J Chron Obstruct Pulmon Dis. 2019 May 13;14:995-1008. doi: 10.2147/COPD.S195382. eCollection 2019.
Similar articles
Patients' perspectives on COPD: findings from a social media listening study.
Cook NS, Kostikas K, Gruenberger JB, Shah B, Pathak P, Kaur VP, Mudumby A, Sharma R, Gutzwiller FS.
ERJ Open Res. 2019 Feb 11;5(1). pii: 00128-2018. doi: 10.1183/23120541.00128-2018. eCollection 2019 Feb.
COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan.
Igarashi A, Fukuchi Y, Hirata K, Ichinose M, Nagai A, Nishimura M, Yoshisue H, Ohara K, Gruenberger JB.
Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2629-2641. doi: 10.2147/COPD.S167476. eCollection 2018.
Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients.
Ställberg B, Janson C, Larsson K, Johansson G, Kostikas K, Gruenberger JB, Gutzwiller FS, Jorgensen L, Uhde M, Lisspers K.
NPJ Prim Care Respir Med. 2018 Sep 10;28(1):33. doi: 10.1038/s41533-018-0101-y.
Economic burden of COPD in a Swedish cohort: the ARCTIC study.
Lisspers K, Larsson K, Johansson G, Janson C, Costa-Scharplatz M, Gruenberger JB, Uhde M, Jorgensen L, Gutzwiller FS, Ställberg B.
Int J Chron Obstruct Pulmon Dis. 2018 Jan 11;13:275-285. doi: 10.2147/COPD.S149633. eCollection 2018.
Greater dyspnea is associated with lower health-related quality of life among European patients with COPD.
Gruenberger JB, Vietri J, Keininger DL, Mahler DA.
Int J Chron Obstruct Pulmon Dis. 2017 Mar 20;12:937-944. doi: 10.2147/COPD.S123744. eCollection 2017.
Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis.
Donohue JF, Betts KA, Du EX, Altman P, Goyal P, Keininger DL, Gruenberger JB, Signorovitch JE.
Int J Chron Obstruct Pulmon Dis. 2017 Jan 19;12:367-381. doi: 10.2147/COPD.S119908. eCollection 2017. Review.
Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal.
Reza Maleki-Yazdi M, Molimard M, Keininger DL, Gruenberger JB, Carrasco J, Pitotti C, Sauvage E, Chehab S, Price D.
Appl Health Econ Health Policy. 2016 Oct;14(5):579-94. doi: 10.1007/s40258-016-0256-z.
Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.
Costa-Scharplatz M, Ställberg B, Goyal P, Asukai Y, Gruenberger JB, Price D.
Appl Health Econ Health Policy. 2015 Dec;13(6):637-45. doi: 10.1007/s40258-015-0193-2.
Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
Viriato D, Calado F, Gruenberger JB, Ong SH, Carvalho D, Silva-Nunes J, Johal S, Viana R.
J Med Econ. 2014 Jul;17(7):499-507. doi: 10.3111/13696998.2014.912986. Epub 2014 Apr 23.
Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
Göke R, Gruenberger JB, Bader G, Dworak M.
Curr Med Res Opin. 2014 May;30(5):785-9. doi: 10.1185/03007995.2013.875464. Epub 2014 Jan 17.
Medical resource use and costs associated with chylomicronemia.
Gaudet D, Signorovitch J, Swallow E, Fan L, Tremblay K, Brisson D, Meyers C, Gruenberger JB.
J Med Econ. 2013;16(5):657-66. doi: 10.3111/13696998.2013.779277. Epub 2013 Mar 11.
Demonstrating the burden of hypoglycemia on patients' quality of life in diabetes clinical trials: measurement considerations for hypoglycemia.
Gilet H, Gruenberger JB, Bader G, Viala-Danten M.
Value Health. 2012 Dec;15(8):1036-41. doi: 10.1016/j.jval.2012.06.002. Epub 2012 Sep 8.
Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs.
Signorovitch JE, Macaulay D, Diener M, Yan Y, Wu EQ, Gruenberger JB, Frier BM.
Diabetes Obes Metab. 2013 Apr;15(4):335-41. doi: 10.1111/dom.12031. Epub 2012 Nov 22.
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.
Rathmann W, Kostev K, Gruenberger JB, Dworak M, Bader G, Giani G.
Diabetes Obes Metab. 2013 Jan;15(1):55-61. doi: 10.1111/j.1463-1326.2012.01674.x. Epub 2012 Sep 9.
Comparative efficacy of vildagliptin and sitagliptin in Japanese patients with type 2 diabetes mellitus: a matching-adjusted indirect comparison of randomized trials.
Signorovitch JE, Wu EQ, Swallow E, Kantor E, Fan L, Gruenberger JB.
Clin Drug Investig. 2011;31(9):665-74. doi: 10.2165/11592490-000000000-00000.
EEG brain mapping in gerontopsychopharmacology: on protective properties of pyritinol against hypoxic hypoxidosis.
Saletu B, Anderer P, Gruenberger J.
Psychiatry Res. 1989 Sep;29(3):387-90. No abstract available.
Filters: Manage Filters